An official website of the United States government
Here's how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Brought to you by the Council of the Inspectors General on Integrity and Efficiency
Federal Reports
Report Date
Agency Reviewed / Investigated
Report Title
Type
Location
Internal Revenue Service
Trends in Compliance Activities Through Fiscal Year 2017
Financial Audit of MCC Resources Managed by Yayasan Pendidikan dan Kesejahteraan Islam Hadji Kalla Under the Agreement with MCA-Indonesia, December 18, 2015, to March 31, 2017
ARC awarded the grant to provide SCC funding support to expand its industrial technology and automotive (the Advanced Manufacturing and Automotive Technology) training programs to it new Cherokee County Campus (CCC).
The grant provided ARC funding to support a project entitled "Wallace State Community College Winston County Works" The project was designed to provide basic skills, workplace skills and technical training to residents in Winston County
Audit of the Office of Justice Programs, Office for Victims of Crime, Victim Assistance Formula Grants Awarded to the Massachusetts Victim and Witness Assistance Board, Boston, Massachusetts
Illicit Fentanyl Use and Urine Drug Screening Practices in a Domiciliary Residential Rehabilitation Treatment Program at the Bath VA Medical Center, New York
The VA Office of Inspector General (OIG) conducted a healthcare inspection to address concerns regarding illicit fentanyl use and urine drug screening (UDS) practices at the Domiciliary Residential Rehabilitation Treatment Program (DRRTP), Bath VA Medical Center, New York. The Veterans Health Administration does not require treatment programs to routinely test for illicit drugs, such as fentanyl, that are trending in the community. In response to incidents involving fentanyl abuse by DRRTP residents, facility leaders amended the UDS policy to include an extended panel UDS that tests for fentanyl. Residents were randomly selected each day for an extended panel UDS. However, the extended panel UDS was processed by a non-VA laboratory with a turnaround time that compromised the timeliness of clinical intervention and overdose prevention. Facility leaders took additional actions to increase the identification of fentanyl use, including the tracking of positive UDS results. The OIG determined that the facility’s fiscal year 2017 positive UDS tracking data was inaccurate. Staff stated there was confusion interpreting the thresholds and some UDS results were incorrectly recorded. To assist DRRTP staff in identifying residents with a history of opioid use and a high-risk for suicide patient record flag, facility leaders implemented a practice of placing color-coded stickers on resident doors. The practice was discussed in the facility’s Mental Health Council meeting; however, key staff reported being unaware of its use for residents at high risk for suicide. OIG staff also found that Domiciliary Assistants did not have sufficient personal protective equipment or training to safely conduct contraband searches of residents’ rooms and belongings. The OIG made eight recommendations related to drug screening guidelines, regional drug abuse identification, timely laboratory turnaround times and result notifications, positive UDS tracking and monitoring, UDS results interpretation training, color-coded sticker practices, and contraband search personal protective equipment and training.